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Previous research associates smaller hippocampal volume with posttraumatic stress disorder (PTSD). It is
unclear, however, whether treatment affects hippocampal volume or vice versa. Seventy-six subjects, 40
PTSD patients and 36 matched trauma-exposed healthy resilient controls, underwent clinical assess-
ments and magnetic resonance imaging (MRI) at baseline, and 10 weeks later, during which PTSD pa-
tients completed ten weeks of Prolonged Exposure (PE) treatment. The resilient controls and treatment
responders (n¼23) had greater baseline hippocampal volume than treatment non-responders (n¼17)
(p¼0.012 and p¼0.050, respectively), perhaps due to more robust fear-extinction capacity in both the
initial phase after exposure to trauma and during treatment.
& 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Previous studies suggest smaller hippocampal volume is a
heritable vulnerability for posttraumatic stress disorder (PTSD)
(Gilbertson et al., 2002). Hippocampal volume has not evinced
change over the course of PTSD post onset (Bonne et al., 2001),
suggesting a trait-like quality. However, current research has not
clarified whether treatment affects hippocampal volume (Apfel
et al., 2011), or whether hippocampal volume influences treatment
response (van Rooij et al., 2015).
Although hippocampal volume increases following psycho-
pharmacological treatment (Vermetten et al., 2003), whether psy-
chotherapy affects hippocampal volume is unclear. Whereas both
Levy-Gigi and colleagues reported increased hippocampal volume
following cognitive behavioral therapy (N¼39) (Levy-Gigi et al., 2013)
and Eye Movement and Desentization and Reprocessing (EMDR)
(N¼10) (Bossini et al., 2011), other researchers failed to find any re-
lationship between hippocampal volume changes and psychotherapy
(Lindauer et al., 2005, (N¼18); van Rooij et al., 2015, (N¼47)).
If hippocampal volume predicts risk of developing PTSD after
trauma, it may also influence treatment response. To examine thisrved.
stitute, 1051 Riverside Drive,
ria).possibility, we evaluated patients with PTSD and resilient trauma-
exposed healthy controls (TEHCs), matched for trauma type and
demographic variables, using magnetic resonance imaging (MRI)
at baseline and 10 weeks later, during which interval PTSD pa-
tients received Prolonged Exposure (PE), a first line cognitive-be-
havioral PTSD treatment (Foa et al., 2008). We hypothesized that
larger baseline hippocampal volume would positively predict PE
treatment response. We also assessed whether PE was associated
with changes in hippocampal volume.2. Methods
Seventy-six participants with adult trauma (PTSD¼40,
TEHC¼36) received assessment by medical examination, the
Structured Clinical Interview for DSM-IV Axis I Disorders (First and
Gibbon, 2004), Clinician-Administered PTSD Scale (CAPS) (Blake
et al., 1995), and Hamilton Depression Rating Scale (HAM-D-17).
Participants answered the Life Events Checklist (LEC) to assess
trauma history and determine duration and number of exposures
to potentially traumatic events. PTSD group exclusion criteria in-
cluded substance/alcohol dependence within the past six months,
or abuse within the past two months; psychotropic medication use
four weeks prior to participation; HAM-D 424, and CAPS o50.
TEHC group exclusion criteria included current or past Axis I
M. Rubin et al. / Psychiatry Research: Neuroimaging 252 (2016) 36–39 37disorders and CAPS 419. PTSD participants' index trauma was to
have occurred after age 16. Participants in the PTSD and TEHC
groups were matched on demographic variables and trauma type.
Treatment response was defined a priori as Z30% reduction from
baseline CAPS score (Brady et al., 2000).
T1-weighted structural images were acquired on a 1.5 T GE
Twin Speed MRI Scanner (TR/TE/Flip angle¼7.25 ms/3 ms/7°;
11 mm in plane 1.3 mm). After inspection for motion artifacts
or gross abnormalities, volume values for both left and right hip-
pocampus were obtained using Freesurfer 5.1 (http://surfer.nmr.
mgh.harvard.edu) standard surface-based reconstruction pipeline
(Dale et al., 1999). PTSD participants received 10 weekly PE ses-
sions. The New York State Psychiatric Institute Institutional Review
Board approved all procedures, and all participants provided
written informed consent.
Analyses compared three groups: treatment responders
(n¼23), TEHCs (n¼36), and non-responders (n¼17). Fourteen
non-responders dropped out before PE ended (five patients
dropped out pre-treatment; four after completing the PE psy-
choeducational component; and five after the first exposure ses-
sion). Within the non-responder group, completers and dropouts
did not differ on any demographic, clinical, or brain volume vari-
ables. Kruskal Wallis tests, t-tests, and one-way analyses ofTable 1
Demographic, clinical, and MRI characteristics.




Age, mean (SD), y 34.4 (8.5) 37.5 (10.7)
Gender, female, % 78 59
Ethnicity
White, n 4 6
African American, n 3 7
Hispanic, n 13 4
Other, n 3 0
Recency of trauma, mean (SD), y 15.8 (14.4) 12.4 (9.3)
Age at primary trauma, mean (SD), y 27.9 (8.8) 32.1 (12.6)
Total number of Traumatic events,
mean (SD)
3.7 (3.6) 3.8 (3.4)
Trauma type
Natural disaster, n 10 4
Fire/explosion, n 4 3
Accident, n 14 6
Toxic exposure, n 2 0
Physical assault, n 8 8
Assault w/ ¼Weapon, n 9 7
Sexual assault, n 11 7
Other sexual contact, n 4 3
Combat, n 4 2
Captivity, n 5 1
Illness or injury, n 2 0
Severe suffering, n 0 2
Violent death, n 6 8
Unexpected death, n 7 5
Terrorism, n 6 0
Other, n 8 2
Baseline CAPS total score, mean (SD) 81.3 (16.4) 81.0 (14.5)
Followup CAPS total score, mean (SD) 23.0 (20.4) 68.0 (10.8)
Baseline HAM-D total score, mean (SD) 16.2 (5.7) 16.5 (5.7)
Followup HAM-D total score, mean
(SD)
8.2 (6.9) 16.3 (5.7)
Lifetime alcohol dependence, n 2 1
Right hippocampus, mean (SD) 4164.8 (405.8) 3912.2 (491.2)
Left hippocampus, mean (SD) 4032.9 (412.5) 3848.1 (569.8
Total hippocampal volume, mean (SD) 8197.7 (792.9) 7760.2 (1042.1
Abbreviation: TEHC, Trauma Exposed Healthy Controls; CAPS, Clinician Administered PT
bAnalysis controlled for sage and sex.
a Analysis controlled for age, sex, and total brain volume.variance (ANOVAs) compared baseline clinical and demographic
data. Baseline hippocampal volumes were compared among the
responder, non-responder, and TE-HC groups using ANCOVA with
post-hoc LSD tests; a Group-by-Time repeated-measures ANCOVA
compared post-treatment volume change. Both analyses con-
trolled for age, sex, and total brain volume (TBV, included to rule
out non-ROI specific trends). All tests were two-tailed with sig-
nificance αo0.05.3. Results
The treatment responders, non-responders and TEHCs did not
differ on demographics or number of traumatic events. In addition,
there were no statistically significant baseline differences in total
brain volume pre- F(2, 74)¼0.070; p40.25, or post-treatment F(2,
50)¼0.93; p40.25. Expected clinical symptom differences and
treatment effects appeared pre- (F (2, 74)¼337; po0.001), and
post- treatment (F (2, 46)¼27.0; po0.001) (see Table 1).
Baseline hippocampal volume showed a significant main effect
of group F(2, 71)¼3.42, p¼0.038, η2¼0.088. Post hoc analyses
indicated treatment responders had larger hippocampal volumes
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3.2 (3.6) F (2, 70)¼337; po0.001
3.3 (6.1) F (2, 46)¼27.0; po0.001
2.2 (2.4) F (2, 70)¼90.1; p¼o0.001
2.9 (3.3) F (2, 46)¼8.6; p¼0.001
0
4221.1 (443.4) F (2, 71)¼3.26; p¼0.04a
) 4093.3 (339.5) F (2, 71)¼2.84; p¼0.06a
) 8315.2 (758.3) F (2, 71)¼3.42; p¼0.038a, η2
¼0.088
SD Scale; HAM-D, Hamilton Rating Scale for Depression.
Fig. 1. Individual Hippocampal Volumes in Study Groups. Abbreviation: TEHCs, Trauma Exposed Healthy Controls.
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Treatment responders and TE-HCs did not differ in hippocampal
volume (p¼0.686) (see Fig. 1). Examination of longitudinal effects
of PE treatment on hippocampal volume revealed no time group
interaction: F(2, 46)¼0.16, p¼0.850, η2¼0.007, suggesting that
hippocampal volume did not change over the course of the
treatment.4. Discussion
Our study found that PTSD patients responsive to PE treatment
and trauma-exposed resilient controls had greater baseline hip-
pocampal volume than treatment non-responders. These findings
support evidence that suggests the hippocampus is key to con-
textual modulation of fear extinction (Ji and Maren, 2007), which
is necessary for accurately distinguishing between contextual cues
that signal safety and those that signal threat (Shin, 2006). Indeed,
recent research linked deficits in this process to a smaller hippo-
campus (Negash et al., 2015). Taken together, our findings indicate
that greater hippocampal volume may not only predict better
prognosis when facing exposure to a traumatic event, but also
better outcome of exposure-based PTSD treatments. This may be
explained by the purported mechanism of change in PE, en-
hancement of safety discrimination during imaginal and in vivo
exposure (Foa, 2007). We found no significant association between
symptomatic improvement following Prolonged Exposure and
change in hippocampal volume, corroborating some previous re-
search (Lindauer et al., 2005; van Rooij et al., 2015).
Several study limitations warrant attention. While the be-
tween-group analysis was significant, the post-hoc analysis re-
vealed only a trend level difference between responders and non-
responders on baseline hippocampal volume. Additionally, the
combination of MRI resolution and version of FreeSurfer used
precluded collecting and analyzing hippocampal sub-region data.
Other limitations include that we did not assess childhood trauma,
overrepresentation (albeit non-significant) of females among PTSD
responders, overall number of dropouts and, more specifically, the
large number of drop-outs in the non-responder group, raising the
possibility that the finding reflects a relationship between smaller
hippocampal volume and treatment drop-out. Treatment attrition
may reflect a difficulty tolerating exposure treatment (Imel et al.,
2013), which may also be tied to similar underlying mechanismsas lack of response. The study deserves replication, and future
studies may be advised to examine the issue of attrition vs. lack of
response, which we were underpowered to explore. Despite these
limitations, we provide new evidence extending current knowl-
edge with regard to the relationship between hippocampal vo-
lume and PTSD. Future research might consider investigating
whether smaller dorsal hippocampus (specifically, CA1 and CA3)
subregions influence treatment response for PTSD, as lesions to
these subregions have been previously associated with impaired
contextual extinction (Ji and Maren, 2008), a process critical to
exposure therapies. We suggest hippocampal volume is a clinically
relevant trait in PTSD, potentially critical to the outcome of PE, a
first-line PTSD treatment for war veterans and civilians.Author contributions
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